Cloudflare, Inc. Class A Common Stock (NET)
107.90
-1.65 (-1.51%)
NYSE · Last Trade: Apr 19th, 2:42 PM EDT
Via The Motley Fool · April 18, 2025
Although the S&P 500 is down 10% over the past six months, Pursuit’s stock price has fallen further to $30.38, losing shareholders 15.1% of their capital. This might have investors contemplating their next move.
Via StockStory · April 18, 2025
Even during a down period for the markets, BrightSpring Health Services has gone against the grain, climbing to $17.29. Its shares have yielded a 8.7% return over the last six months, beating the S&P 500 by 17.6%. This run-up might have investors contemplating their next move.
Via StockStory · April 17, 2025
Shareholders of Benchmark would probably like to forget the past six months even happened. The stock dropped 20.7% and now trades at $35.66. This might have investors contemplating their next move.
Via StockStory · April 17, 2025
Via Benzinga · April 16, 2025
Cybersecurity stocks are showing resilience amid a downturn in the technology sector.
Via Investor's Business Daily · April 16, 2025
Since October 2024, PAR Technology has been in a holding pattern, posting a small loss of 3% while floating around $55.35.
Via StockStory · April 15, 2025
Enviri’s stock price has taken a beating over the past six months, shedding 36.6% of its value and falling to $6.59 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 15, 2025
In a sliding market, Gilead Sciences has defied the odds, trading up to $106.42 per share. Its 24% gain since October 2024 has outpaced the S&P 500’s 6.9% drop. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · April 15, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the software development industry, including JFrog (NASDAQ:FROG) and its peers.
Via StockStory · April 14, 2025
Things are hog wild at Harley-Davidson; Plus, Impresoft, Keros Therapeutics and Rivalry Corp. are all itching for a deal.
Via Benzinga · April 11, 2025
The ONE Group has gotten torched over the last six months - since October 2024, its stock price has dropped 20.8% to $2.85 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · April 11, 2025
Via Benzinga · April 10, 2025
Carrier Global’s stock price has taken a beating over the past six months, shedding 25.4% of its value and falling to $59.98 per share. This might have investors contemplating their next move.
Via StockStory · April 10, 2025
iRhythm has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78.8%, reaching $102.62 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · April 10, 2025
Terex has gotten torched over the last six months - since October 2024, its stock price has dropped 33.6% to $35.28 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 10, 2025
Trimble has been treading water for the past six months, recording a small loss of 1.9% while holding steady at $60.57. However, the stock is beating the S&P 500’s 7.8% decline during that period.
Via StockStory · April 10, 2025
Genuine Parts has gotten torched over the last six months - since October 2024, its stock price has dropped 22.6% to a new 52-week low of $103.50 per share. This may have investors wondering how to approach the situation.
Via StockStory · April 9, 2025
Shareholders of Flex would probably like to forget the past six months even happened. The stock has dropped 23% and now trades at a new 52-week low of $26.21. This might have investors contemplating their next move.
Via StockStory · April 9, 2025
The Pennant Group has gotten torched over the last six months - since October 2024, its stock price has dropped 28.3% to $24.33 per share. This might have investors contemplating their next move.
Via StockStory · April 9, 2025
The past six months haven’t been great for Sarepta Therapeutics. It just made a new 52-week low of $52, and shareholders have lost 56.6% of their capital. This may have investors wondering how to approach the situation.
Via StockStory · April 8, 2025
Albany trades at $62.35 per share and has stayed right on track with the overall market, losing 14.4% over the last six months while the S&P 500 is down 10.6%. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · April 8, 2025